How many studies have been conducted on Pembrolizumab?

BiohacksAI has indexed 1,002 PubMed studies on Pembrolizumab, including 335 randomized controlled trials (RCTs). 97% of studies involve human subjects.

What are the main research areas for Pembrolizumab?

The primary research domains for Pembrolizumab are 🔬 Oncology, 🛡️ Immunity, 🫘 Kidney. This is based on analysis of 1,002 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Pembrolizumab

pembrolizumab [Supplementary Concept]

1.0k+ PubMed studies analyzed · 335 RCTs · Evidence Score: 73.3

Research Domains

Pembrolizumab has been studied across 9 research domains including 🔬 Oncology, 🛡️ Immunity, 🫘 Kidney, ⏳ Longevity & Aging, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 94% of studies addressing this area.

Loading evidence profile...

This evidence profile for Pembrolizumab is generated deterministically from 1,002 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.